SciELO - Scientific Electronic Library Online

 
vol.20 número2Farmacovigilancia del Midazolam en Pacientes sometidos a Estudios GastroscópicosPapel de los Calcio-Antagonistas en el control de eventos Vaso-Oclusivos y Hemolíticos en Drepanocitosis. Estudio piloto con Nitrendipina índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Archivos Venezolanos de Farmacología y Terapéutica

versión impresa ISSN 0798-0264

Resumen

MISLE, AJ et al. G-Protein-Dependent Antagonists Binding In M3 mAchR from Tracheal Smooth Muscle. AVFT [online]. 2001, vol.20, n.2, pp.143-151. ISSN 0798-0264.

The M3 and M2 mAchR subtypes were located in plasma membranes fractions from bovine tracheal smooth muscle (BTSM). Native mAchRs from BTSM were studied by using [3H]QNB binding. Receptor heterogeneity was expressed for muscarinic agonists and antagonists being the high affinity states sensitive to GTPgS. We showed that GTPgS effects seem to be mediated by PTX sensitive Gi/o proteins. Antagonist mAchR heterogeneity towards 4-DAMP (M3) and pirenzepine (M1) was detected. However, M2 antagonists as methoctramine and AF-DX 116 did not show such responses either in the presence or absence of GTPgS. Through 4-DAMP alkylation of the M3 mAchR subtype, a M2 subtype prevailed, which exhibits GTPgS-dependent agonist binding whereas antagonist binding was GTPgS-insensitive. Thus, antagonists binding receptor heterogeneity here described is due to the M3 mAchR subtype showing two affinity states, one being regulated by Gi/o-proteins.

Palabras clave : Muscarinic agonists; Muscarinic antagonists; Pertussis toxin; GTPgS; Tracheal smooth muscle.

        · resumen en Español     · texto en Inglés